Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Tromp, Noor
and
Baltussen, Rob
2012.
Mapping of multiple criteria for priority setting of health interventions: an aid for decision makers.
BMC Health Services Research,
Vol. 12,
Issue. 1,
Soto Álvarez, Javier
2012.
Evaluación económica de medicamentos y tecnologías sanitarias:.
p.
305.
Norheim, Ole Frithjof
2012.
Priority setting: the importance of incorporating opportunity costs.
Israel Journal of Health Policy Research,
Vol. 1,
Issue. 1,
Giacomini, Mita
Winsor, Shawn
and
Abelson, Julia
2013.
Ethics in Health Technology Assessment: Understanding Health Technologies as Policies.
Healthcare Management Forum,
Vol. 26,
Issue. 2,
p.
72.
Hofmann, Bjørn
Cleemput, Irina
Bond, Kenneth
Krones, Tanja
Droste, Sigrid
Sacchini, Dario
and
Oortwijn, Wija
2014.
REVEALING AND ACKNOWLEDGING VALUE JUDGMENTS IN HEALTH TECHNOLOGY ASSESSMENT.
International Journal of Technology Assessment in Health Care,
Vol. 30,
Issue. 6,
p.
579.
McLeod, Melissa
Blakely, Tony
Kvizhinadze, Giorgi
and
Harris, Ricci
2014.
Why equal treatment is not always equitable: the impact of existing ethnic health inequalities in cost-effectiveness modeling.
Population Health Metrics,
Vol. 12,
Issue. 1,
Norheim, Ole F
Baltussen, Rob
Johri, Mira
Chisholm, Dan
Nord, Erik
Brock, DanW
Carlsson, Per
Cookson, Richard
Daniels, Norman
Danis, Marion
Fleurbaey, Marc
Johansson, Kjell A
Kapiriri, Lydia
Littlejohns, Peter
Mbeeli, Thomas
Rao, Krishna D
Edejer, Tessa Tan-Torres
and
Wikler, Dan
2014.
Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis.
Cost Effectiveness and Resource Allocation,
Vol. 12,
Issue. 1,
p.
18.
Strømme, Elisabeth Marie
Bærøe, Kristine
and
Norheim, Ole Frithjof
2014.
Disease Control Priorities for Neglected Tropical Diseases: Lessons from Priority Ranking Based on the Quality of Evidence, Cost Effectiveness, Severity of Disease, Catastrophic Health Expenditures, and Loss of Productivity.
Developing World Bioethics,
Vol. 14,
Issue. 3,
p.
132.
Schlander, Michael
Garattini, Silvio
Holm, Søren
Kolominsky-Rabas, Peter
Nord, Erik
Persson, Ulf
Postma, Maarten
Richardson, Jeff
Simoens, Steven
Solà Morales, Oriol de
Tolley, Keith
and
Toumi, Mondher
2014.
Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders.
Journal of Comparative Effectiveness Research,
Vol. 3,
Issue. 4,
p.
399.
Johansson, Kjell Arne
Memirie, Solomon Tessema
Pecenka, Clint
Jamison, Dean T.
Verguet, Stéphane
and
Griffiths, Ulla Kou
2015.
Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis.
PLOS ONE,
Vol. 10,
Issue. 12,
p.
e0142691.
Welch, Vivian
Petticrew, Mark
Petkovic, Jennifer
Moher, David
Waters, Elizabeth
White, Howard
and
Tugwell, Peter
2015.
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
International Journal for Equity in Health,
Vol. 14,
Issue. 1,
Schmidt, Harald
and
Barnhill, Anne
2015.
Equity and Noncommunicable Disease Reduction under the Sustainable Development Goals.
PLOS Medicine,
Vol. 12,
Issue. 9,
p.
e1001872.
Panteli, Dimitra
Kreis, Julia
and
Busse, Reinhard
2015.
CONSIDERING EQUITY IN HEALTH TECHNOLOGY ASSESSMENT: AN EXPLORATORY ANALYSIS OF AGENCY PRACTICES.
International Journal of Technology Assessment in Health Care,
Vol. 31,
Issue. 5,
p.
314.
Welch, Vivian
Petticrew, Mark
Petkovic, Jennifer
Moher, David
Waters, Elizabeth
White, Howard
Tugwell, Peter
and
the PRISMA-Equity Bellagio group
2016.
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Journal of Development Effectiveness,
Vol. 8,
Issue. 2,
p.
287.
Carter, Drew
Gordon, Jason
and
Watt, Amber M.
2016.
Competing Principles for Allocating Health Care Resources.
Journal of Medicine and Philosophy,
Vol. 41,
Issue. 5,
p.
558.
Welch, Vivian
Petticrew, Mark
Petkovic, Jennifer
Moher, David
Waters, Elizabeth
White, Howard
Tugwell, Peter
Atun, Rifat
Awasthi, Shally
Barbour, Virginia
Bhutta, Zulfiqar A.
Cuervo, Luis Gabriel
Groves, Trish
Koehlmoos-Perez, Tracey
Kristjansson, Elizabeth
Moher, David
Oxman, Andy
Pantoja, Tomas
Petticrew, Mark
Petkovic, Jennifer
Pigott, Terri
Ranson, Kent
TanTorres, Tessa
Tharyan, Prathap
Tovey, David
Tugwell, Peter
Volmink, Jimmy
Wager, Elizabeth
Waters, Elizabeth
Welch, Vivian
Wells, George
and
White, Howard
2016.
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Journal of Clinical Epidemiology,
Vol. 70,
Issue. ,
p.
68.
Price, Joan T.
Wheeler, Stephanie B.
Stranix-Chibanda, Lynda
Hosek, Sybil G.
Watts, D. Heather
Siberry, George K.
Spiegel, Hans M. L.
Stringer, Jeffrey S.
and
Chi, Benjamin H.
2016.
Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
JAIDS Journal of Acquired Immune Deficiency Syndromes,
Vol. 72,
Issue. 2,
p.
S145.
Baltussen, Rob
Jansen, Maarten P.
Mikkelsen, Evelinn
Tromp, Noor
Hontelez, Jan
Bijlmakers, Leon
and
Van der Wilt, Gert Jan
2016.
Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness.
International Journal of Health Policy and Management,
Vol. 5,
Issue. 11,
p.
615.
Culyer, Anthony J.
2016.
HTA – Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
International Journal of Health Policy and Management,
Vol. 5,
Issue. 8,
p.
501.
Schmitz, Susanne
McCullagh, Laura
Adams, Roisin
Barry, Michael
and
Walsh, Cathal
2016.
Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland.
PharmacoEconomics,
Vol. 34,
Issue. 9,
p.
925.